Bharat Biotech's nasal Covid vaccine launched
The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose
Representational image
New Delhi: Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.
The world’s first made-in-India intranasal vaccine was launched at Mandaviya’s residence here.
The nasal vaccine — BBV154 — had received the Drugs Controller General of India’s (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.
According to a statement issued by Bharat Biotech earlier, ‘iNCOVACC’ is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments.
iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, the Hyderabad-based vaccine maker had said.
Clinical trials were conducted to evaluate iNCOVACC as a primary dose schedule and as a heterologous booster dose for subjects who have previously received two doses of either Covishield or Covaxin.
Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
also read
World happier than before Covid pandemic; West slightly lesser than others: Global Happiness Index
"People eventually learned who their neighbours were. They took care of the senior citizens, so the isolation was less severe than you might anticipate. Positive emotions have remained twice as common as negative ones even during these challenging years
WHO accuses China of hiding data on coronavirus origin
The WHO rebuked Chinese officials for withholding scientific research that may reveal the origin of the coronavirus and also asked them about the reasons behind not revealing the data three years ago and why, after it was published online in January, it could not be found now.
India sees record six-month high in COVID cases: Is it time to worry?
India recorded 3,016 new COVID-19 cases in the past 24 hours — a 40 per cent jump since the day before. Experts attribute the rise in infections to the emergence of the XBB.1.16 Omicron variant, which has a high transmission rate